Bradstock K, Makrynikola V, Bianchi A, Byth K
Haematology Department, Westmead Hospital, New South Wales, Australia.
Blood. 1993 Dec 1;82(11):3437-44.
Normal B lymphopoiesis is dependent on a close relationship between B-cell precursors and the bone marrow (BM) microenvironment. To further understand the mechanisms regulating the proliferation of the malignant counterpart of B-cell precursors, namely precursor-B acute lymphoblastic leukemia (ALL), we examined the adhesion to BM fibroblasts (BMF) of 19 cases of precursor-B ALL using a chromium labeling assay. Eleven of 19 cases showed greater than 10% binding to BMF (range 2.3% to 54.8%, mean 19.1%). Binding was increased approximately twofold by preincubation of BMF with tumor necrosis factor and interleukin-4, which also resulted in upregulation of expression of vascular cell adhesion molecule-1 (VCAM-1) on BMF. The mechanism of attachment was investigated using murine monoclonal antibodies to leukocyte integrins, principally the beta, integrins VLA-4 and VLA-5, which were demonstrated to be present on most cases by flow cytometry. Statistically significant inhibition of adhesion was observed with antibodies to the beta 1 common subunit, VLA-4, and VLA-5, whereas little effect was seen with antibodies to VLA-6 or the beta 2 integrin subunit. Preincubation of fibroblasts with an antibody to VCAM-1 (a ligand of VLA-4) inhibited leukemic cell binding in the majority of cases, which was an effect also observed on cytokine-stimulated BMF. However, a minority of cases, as well as the pre-B lines NALM-6 and KM-3, showed no evidence of inhibition of adhesion with anti-VCAM-1 antibodies. Treatment of BMF with antifibronectin antibody alone had little effect on ALL adhesion and did not enhance the inhibitory effect of anti-VCAM-1. These data indicate that precursor-B ALL cells bind to BM stroma through the beta 1 integrins VLA-4 and VLA-5 and that this effect is partly mediated by VCAM-1 on stromal cells, although other undefined VLA ligands are also likely to be involved. Attachment of ALL cells to stroma is likely to play a key role in regulating the survival and growth of these cells through exposure to stromal cytokines.
正常的B淋巴细胞生成依赖于B细胞前体与骨髓(BM)微环境之间的密切关系。为了进一步了解调节B细胞前体恶性对应物(即前体B急性淋巴细胞白血病(ALL))增殖的机制,我们使用铬标记试验检测了19例前体B ALL对骨髓成纤维细胞(BMF)的粘附情况。19例中有11例显示与BMF的结合率大于10%(范围为2.3%至54.8%,平均为19.1%)。通过将BMF与肿瘤坏死因子和白细胞介素-4预孵育,结合率增加了约两倍,这也导致BMF上血管细胞粘附分子-1(VCAM-1)的表达上调。使用针对白细胞整合素的鼠单克隆抗体,主要是β1整合素VLA-4和VLA-5,研究了粘附机制,流式细胞术显示大多数病例中都存在这些整合素。用针对β1共同亚基、VLA-4和VLA-5的抗体观察到粘附的统计学显著抑制,而针对VLA-6或β2整合素亚基的抗体几乎没有效果。用针对VCAM-1(VLA-4的配体)的抗体预孵育成纤维细胞在大多数病例中抑制了白血病细胞的结合,在细胞因子刺激的BMF上也观察到了这种效果。然而,少数病例以及前B细胞系NALM-6和KM-3,没有显示出抗VCAM-1抗体抑制粘附的证据。单独用抗纤连蛋白抗体处理BMF对ALL粘附几乎没有影响,也没有增强抗VCAM-1的抑制作用。这些数据表明,前体B ALL细胞通过β1整合素VLA-4和VLA-5与BM基质结合,并且这种作用部分由基质细胞上的VCAM-1介导,尽管其他未明确的VLA配体也可能参与其中。ALL细胞与基质的附着可能通过暴露于基质细胞因子在调节这些细胞的存活和生长中起关键作用。